S&P 500$7,365.46
-1.44%
2m
DOW 30$51,666.84
-0.09%
2m
NASDAQ 100$29,347.27
-3.29%
2m
Russell 2000$295.32
-0.96%
2m
Russell 1000$401.57
-1.32%
2m
S&P 400$3,767.24
-1.04%
2m
S&P 600$1,738.62
-0.36%
2m

PetMed Express (PETS)

NASDAQ

$1.86+$0.03 (+1.64%)

Price as of Jun 23, 2026 7:21 PM EDT

$38.7M
Market Cap
-44.21%
1-Year Change
Pharmaceutical Retailers
Industry

Annual

Quarterly

	03/31/2026	03/31/2025	03/31/2024	03/31/2023
Income Statement
Total Operating Revenue	179.0M -21.13%	227.0M -19.25%	281.1M +9.54%	256.6M -6.16%
Cost of Revenue	128.8M -18.39%	157.8M -22.02%	202.4M +8.92%	185.8M -4.86%
Gross Profit	50.2M -27.37%	69.1M -12.09%	78.6M +11.19%	70.7M -9.40%
Sales and Marketing Expense	21.5M -9.55%	23.8M -2.97%	24.5M +26.17%	19.4M +3.32%
Research and Development Expense	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Depreciation and Amortization Expense	9.4M +33.36%	7.0M -0.24%	7.1M +98.98%	3.5M +29.51%
Total Operating Expenses	108.9M +54.09%	70.7M -18.60%	86.8M +34.21%	64.7M +23.52%
Operating Profit	-58.7M +3,734.84%	-1.5M -81.25%	-8.2M -234.89%	6.1M -76.46%
Interest Income	N/A N/A	N/A N/A	N/A N/A	2.1M +517.91%
Interest Expense	N/A N/A	N/A N/A	N/A N/A	-1.6M N/A
Interest Income and Expense and Net	0 N/A	0 N/A	0 -100.00%	450,000 +34.33%
Total Nonoperating Income and Expense	1.3M +39.34%	943,000 -50.08%	1.9M +35.51%	1.4M +2.42%
Income before Taxes	-57.4M +9,671.55%	-587,000 -90.64%	-6.3M -184.26%	7.4M -72.50%
Income Taxes	-73,000 -101.28%	5.7M +377.25%	1.2M -48.33%	2.3M -61.40%
Extraordinary Items	27.3M +2,171.50%	1.2M N/A	N/A N/A	N/A N/A
Net Income	-57.3M +813.51%	-6.3M -15.98%	-7.5M -245.21%	5.1M -75.64%
Net Income from Continuing Operations Applicable to Common	-57.4M +9,671.55%	-587,000 -90.64%	-6.3M -184.26%	7.4M -72.50%
Basic EPS and Net Income	-2.74 +813.33%	-0.30 -18.92%	-0.37 -248.00%	0.25 -76.19%
Diluted EPS and Net Income	-2.74 +813.33%	-0.30 -18.92%	-0.37 -248.00%	0.25 -75.96%
Basic Weighted Average Shares	20.9M +1.58%	20.6M +0.98%	20.4M +0.60%	20.3M +0.49%
Diluted Weighted Average Shares	20.9M +1.58%	20.6M +0.98%	20.4M +0.28%	20.3M -0.09%
Balance Sheet
Cash and Cash Equivalents	21.4M -60.87%	54.7M -1.04%	55.3M -46.87%	104.1M -6.30%
Short-Term Investments	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash and Cash Equivalents and Short-Term Investments	21.4M -60.87%	54.7M -1.04%	55.3M -46.87%	104.1M -6.30%
Total Current Assets	43.6M -44.77%	78.9M -15.78%	93.6M -28.20%	130.4M -13.62%
Accumulated Depreciation	31.9M +26.58%	25.2M +25.25%	20.1M +32.15%	15.2M +30.35%
Property and Plant and Equipment and Net	26.3M -8.78%	28.9M +8.26%	26.7M +1.83%	26.2M +7.01%
Total Long-Term Assets	37.6M -46.12%	69.8M -8.40%	76.2M +105.78%	37.0M +46.29%
Total Assets	81.2M -45.40%	148.7M -12.47%	169.9M +1.44%	167.5M -5.01%
Income Taxes Payable	22.5M -10.92%	25.2M +0.79%	25.0M -4.22%	26.1M +2,689.85%
Total Short-Term Debt	N/A N/A	N/A N/A	N/A N/A	260,000 0.00%
Total Current Liabilities	52.0M -17.10%	62.8M -13.01%	72.2M +25.47%	57.5M +73.24%
Total Long-Term Debt	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Long-Term Liabilities	392,000 -63.05%	1.1M +6.63%	995,000 N/A	0 -100.00%
Total Liabilities	52.3M -17.80%	63.6M -13.11%	73.2M +27.20%	57.5M +68.49%
Retained Earnings	9.3M -86.08%	66.5M -7.00%	71.6M -21.93%	91.7M -29.76%
Total Stockholders Equity	28.9M -66.01%	85.1M -11.99%	96.7M -12.04%	110.0M -22.66%
Total Shares Outstanding	21.4M +3.53%	20.7M -2.33%	21.1M +0.31%	21.1M +0.50%
Cash Flow
Cash from Operating Activities	-28.4M -701.82%	4.7M +9.29%	4.3M -84.47%	27.8M +50.30%
Capital Expenditures	4.6M -9.74%	5.1M +13.35%	4.5M -14.24%	5.3M +200.23%
Cash from Investing Activities	-4.6M -9.74%	-5.1M -87.43%	-40.7M +296.39%	-10.3M +485.62%
Dividends Paid	21,000 -88.40%	181,000 -98.54%	12.4M -49.31%	24.5M +0.63%
Cash from Financing Activities	-299,000 +65.19%	-181,000 -98.54%	-12.4M -49.31%	-24.5M +0.63%
Financials Ratio
Gross Margin	28.05% -7.91%	30.46% +8.86%	27.98% +1.50%	27.57% -3.46%
Operating Margin	-32.77% +4,761.95%	-0.67% -76.79%	-2.90% -223.14%	2.36% -74.92%
Return on Assets	-49.84% +1,165.94%	-3.94% -11.03%	-4.42% -247.99%	2.99% -74.22%
Return on Equity	-100.44% +1,356.38%	-6.90% -4.51%	-7.22% -277.15%	4.08% -72.61%
Revenue Growth	-21.13% +9.77%	-19.25% -301.67%	9.54% +254.96%	-6.16% -46.81%
Current Ratio	0.84 -33.37%	1.26 -3.18%	1.30 -42.78%	2.27 -50.14%
Cash Ratio	0.41 -52.80%	0.87 +13.77%	0.77 -57.66%	1.81 -45.91%
Debt-to-Equity Ratio	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Debt-to-Assets Ratio	N/A N/A	N/A N/A	N/A N/A	N/A N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow